Stocks Radar: Jet Airways, Kesoram Industries, Lupin, Tata Motors
Indian equity benchmarks opened lower on Wednesday following Asian peers amid the biggest slide in stocks on Wall Street since the mid-October downdraft. The S&P BSE Sensex and the NSE Nifty 50 Index traded nearly 0.7 percent lower at 35,911.83 and 10,789.45, respectively, as of 10:05 a.m.
The market breadth was tilted in favour of sellers. All sectoral gauges declined, led by a 1.74 percent fall in the NSE Nifty Metal Index.
Here Are The Stocks Moving The Market Today
Tata Motors Worst Performer On Nifty, Sensex
Shares of the carmaker snapped its two-day gaining streak and fell as much as 3.2 percent to Rs 170.10 apiece.
Global research firm S&P downgraded Tata Motors-owned Jaguar Land Rover to ‘BB-' from ‘BB', according to the credit-rating agency's press statement. JLR's bond risk more than quadrupled this year as the automaker faces uncertainty in Europe over its diesel vehicles and Brexit as well as weaker demand in China, Bloomberg reported.
The stock, the worst performer on the Sensex and the Nifty, traded 51.2 percent below the Bloomberg consensus one-year target price.
Jet Airways Gains On Report Of Getting New Investor
Shares of the cash-strapped airline gained as much as 2.8 percent to Rs 311.75 apiece.
Jet Airways would bring on board a new investor in two to three months to help fund the cash-strapped airline, Chief Executive Officer Vinay Dube told the airline's pilots, Mint reported quoting anonymous sources.
The stock declined 63 percent so far this year compared to a 6.6 percent gain in the BSE Sensex, according to Bloomberg data.
Oil Retailers Jump As Crude Falls To $60 A Barrel
Shares of oil marketing companies gained as Brent crude futures fell 2.1 percent to $60.80 a barrel.
- Indian Oil gained nearly 2 percent to Rs 138.20 apiece.
- Hindustan Petroleum Corporation advanced 1.7 percent to Rs 232 apiece.
- Bharat Petroleum Corporation rose 1.5 percent to Rs 338.65 apiece.

Lupin Swings After Drug Launch
Shares of the drugmaker pared opening gains and fell nearly 2 percent to Rs 870 apiece.
Lupin launched Silodosin Capsules after it received an approval from the U.S. FDA, according to its notification on the bourses. This drug is used for the treatment of benign prostatic hyperplasia.
The stock traded at 33 times its estimated earnings per share for the coming year, according to Bloomberg data.
Kesoram Industries Falls After Board Approves Demerger Of Tyre Business
Shares of the building materials maker declined as much as 4.7 percent to Rs 92.65 apiece.
The board of Kesoram Industries approved the proposal to demerge the tyre business into a new entity, Birla Tyres Ltd. Also, Jan. 1, 2019 has been fixed as the appointment date for the spin-off, according to an exchange filing. Birla Tyres will issue 1:1 equity share to Kesoram Industries at a nominal value of Rs 10 a share.
The stock fell 31 percent so far this year compared to a 9.9 percent gain in the BSE Sensex, Bloomberg data showed.
Kridhan Infra Surges After Bagging New Deal
Shares of the steel producer rose as much as 10.4 percent to Rs 52 apiece.
Kridhan Infra's arm Vijay Nirman Company received an order worth Rs 105 crore for a highway project in Maharashtra, according to its exchange notification. The company has been mandated to construct bridges for Mumbai-Nagpur Super Communication Expressway.
The trading volume was 16 times the 20-day average for this time of the day, Bloomberg data showed.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.